Long-term sufferers of insomnia who have not found lasting relief from such sleep aids as Ambien or Sonta should consider researching Rozerem, the only medication of its type approved in the treatment of sleeplessness. Rozerem (ramelteon) is the first of a new class of insomnia drugs: melatonin receptor agonists. These are similar to the naturally-produced [...]
Entries Tagged as 'Rozerem'
Insomnia info: Rozerem is a sleeplessness treatment in its very own class
September 8th, 2009 · No Comments
Tags: Ambien · Drug interactions · FDA · Lunesta · Medical information · Prescription drugs · Prescriptions · Rozerem
An interview with John Mack of Pharma Marketing Blog
April 2nd, 2007 · 1 Comment
One of our favorite industry pundits is John Mack, author of Pharma Marketing News, Pharma Marketing Blog and The Pharma Blogosphere, and host of Pharma Marketing Talk. We recently asked him about his background, his readership and some current issues in pharma. Cary: You started VirSci Pharma Marketing Network in 1997 and it has since [...]
Tags: Pharma bloggers · Rozerem
What happens when Big Pharma endangers kiddies? They get a strongly worded letter, of course
March 13th, 2007 · No Comments
Takeda Pharmaceuticals North American, Inc. has been cited by the FDA for airing unapproved reminder ads for its sleep aid medication Rozerem. Here’s an excerpt from the citation letter, courtesy of PharmaLive: While reminder ads are exempt from the requirement to disclose information relating to risks and effectiveness, for the reasons set forth below, we [...]
Tags: Pharmaceutical marketing · Rozerem